CTOs on the Move

Brown Physicians

www.brownphysicians.org

 
Brown Physicians, Incorporated (BPI) is a community-based not-for-profit multi-specialty practice group founded and led by faculty affiliated with The Warren Alpert Medical School of Brown University. Our mission is to provide outstanding patient care, exceptional medical education, and groundbreaking advances in research to promote better health for the people of Rhode Island and its surrounding communities. BPI is composed of six foundations, which include Brown Dermatology, Brown Emergency Medicine, Brown Medicine, Brown Neurology, Brown Urology, and University Surgical Associates.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Atlantic AllCare

Atlantic AllCare is a Deerfield Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CVS Caremark

San Antonio AIDS Foundation

San Antonio AIDS Foundation is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

McDougall Scientific

McDougall Scientific Ltd is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Enterin Inc.

Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.